Cancer Discovery Journal Citation Rate 2026

ISSN 2159-8274 eISSN 2159-8290 American Association for Cancer Research US

Q1 Quartile Top Tier

About Cancer Discovery
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Cancer Discovery (CD) is a peer-reviewed academic journal, published by American Association for Cancer Research in US, catalogued under ISSN 2159-8274 (e-ISSN 2159-8290). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 6.22 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.

Cancer Discovery Citation Rate 2026 — In Context

Cancer Discovery has a 2025 2-Year Citation Rate (OpenAlex) of 6.22, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Cancer Discovery operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Cancer Discovery should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cancer Discovery against similar journals in the field, use our journal comparison tool.

ISSN (Print) 2159-8274
ISSN (Online) 2159-8290
Publisher American Association for Cancer Research
Country United States
APC / Cost Inquire with Publisher
h-index 305
Total Works 8,066
Total Citations 364,948
2-yr Mean Citedness 7.53 (OpenAlex)
In-depth profile & metrics

Cancer Discovery is published by American Association for Cancer Research and based in United States.

Editorially, Cancer Discovery concentrates on Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics and CAR-T cell therapy research.

Cancer Discovery is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

OpenAlex records 8,066 works that have together drawn 364,948 citations, giving the journal an h-index of 305; its most recent citation rate stands at 6.218; OpenAlex puts its two-year mean citedness at 7.53.

Links
Frequently Asked Questions about Cancer Discovery

Cancer Discovery does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 6.218 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Cancer Discovery is not an open access journal.

Cancer Discovery is published by American Association for Cancer Research.

Cancer Discovery shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Cancer Discovery is 2159-8274. Its electronic ISSN (eISSN) is 2159-8290.

Cancer Discovery sits in the Q1 quartile based on its latest impact factor of 6.22, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
6.218
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 6.218 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.


Works Published per Year (2014–2025)

Annual publication volume sourced from OpenAlex. Current year omitted (partial data).

Publication & citation history by year
YearWorks publishedCitations received
2025 400 1,871
2024 486 7,005
2023 507 9,213
2022 532 23,843
2021 553 31,368
2020 523 27,065
2019 493 28,957
2018 541 34,090
2017 560 29,915
2016 546 28,711
2015 561 30,169
2014 609 28,347
Journal at a Glance
8,066
Total Works
364,948
Total Citations
305
h-index
7.53
2-Yr Mean Citedness

Source: OpenAlex — refreshed daily.

Top Research Topics

The areas where Cancer Discovery most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.

Cancer Genomics and Diagnostics
Biochemistry, Genetics and Molecular Biology
761 works
601 works
Epigenetics and DNA Methylation
Biochemistry, Genetics and Molecular Biology
444 works
Immunotherapy and Immune Responses
Immunology and Microbiology
407 works
Immune Cell Function and Interaction
Immunology and Microbiology
344 works
Cancer, Hypoxia, and Metabolism
Biochemistry, Genetics and Molecular Biology
321 works
Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S2486275289

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google